FierceBiotech ٢ فبراير ٢٠٢٦ Early-stage investor Santé Ventures gins up $330M to spread across biotech, medtech and digital health
FierceBiotech ٢ فبراير ٢٠٢٦ China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug
FierceBiotech ٢ فبراير ٢٠٢٦ Daiichi stops internal development of next-wave ADC as key Datroway readout delayed again
FierceBiotech ٢ فبراير ٢٠٢٦ Sanofi's troubled GCS inhibitor fails phase 3 Fabry trial but scores in Gaucher disease
FierceBiotech ٢ فبراير ٢٠٢٦ AstraZeneca study finds 22 genes tied to chronic disease risk after Epstein-Barr infection
FierceBiotech ٣٠ يناير ٢٠٢٦ Corcept submitted lead asset for approval despite FDA flagging risk of ‘significant review issues’
FierceBiotech ٣٠ يناير ٢٠٢٦ Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
FierceBiotech ٣٠ يناير ٢٠٢٦ Chugai drops only AI-assisted antibody from pipeline but still holds high hopes for tech